These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 21598296)

  • 1. Synthesis and pharmacological evaluation of a potent and selective σ1 receptor antagonist with high antiallodynic activity.
    Utech T; Köhler J; Buschmann H; Holenz J; Vela JM; Wünsch B
    Arch Pharm (Weinheim); 2011 Jul; 344(7):415-21. PubMed ID: 21598296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of 4-(aminoalkyl) substituted 1,3-dioxanes as potent NMDA and σ receptor antagonists.
    Utech T; Köhler J; Wünsch B
    Eur J Med Chem; 2011 Jun; 46(6):2157-69. PubMed ID: 21444132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological and metabolic characterisation of the potent sigma1 receptor ligand 1'-benzyl-3-methoxy-3H-spiro[[2]benzofuran-1,4'-piperidine].
    Wiese C; Grosse Maestrup E; Schepmann D; Vela JM; Holenz J; Buschmann H; Wünsch B
    J Pharm Pharmacol; 2009 May; 61(5):631-40. PubMed ID: 19406002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination of two pharmacophoric systems: synthesis and pharmacological evaluation of spirocyclic pyranopyrazoles with high σ₁ receptor affinity.
    Schläger T; Schepmann D; Lehmkuhl K; Holenz J; Vela JM; Buschmann H; Wünsch B
    J Med Chem; 2011 Oct; 54(19):6704-13. PubMed ID: 21859078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tetrahydro-3-benzazepines with fluorinated side chains as NMDA and σ
    Thum S; Schepmann D; Ayet E; Pujol M; Nieto FR; Ametamey SM; Wünsch B
    Eur J Med Chem; 2019 Sep; 177():47-62. PubMed ID: 31129453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel Potent N-Methyl-d-aspartate (NMDA) Receptor Antagonists or σ1 Receptor Ligands Based on Properly Substituted 1,4-Dioxane Ring.
    Bonifazi A; Del Bello F; Mammoli V; Piergentili A; Petrelli R; Cimarelli C; Pellei M; Schepmann D; Wünsch B; Barocelli E; Bertoni S; Flammini L; Amantini C; Nabissi M; Santoni G; Vistoli G; Quaglia W
    J Med Chem; 2015 Nov; 58(21):8601-15. PubMed ID: 26430967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of conformationally restricted 1,3-dioxanes to analyze the bioactive conformation of 1,3-dioxane-based σ
    Asare-Nkansah S; Schepmann D; Wünsch B
    Bioorg Med Chem; 2017 Apr; 25(8):2472-2481. PubMed ID: 28320613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and structure-activity relationship study of a new series of selective σ(1) receptor ligands for the treatment of pain: 4-aminotriazoles.
    Díaz JL; Christmann U; Fernández A; Torrens A; Port A; Pascual R; Álvarez I; Burgueño J; Monroy X; Montero A; Balada A; Vela JM; Almansa C
    J Med Chem; 2015 Mar; 58(5):2441-51. PubMed ID: 25658964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel vanilloid receptor-1 antagonists: 1. Conformationally restricted analogues of trans-cinnamides.
    Norman MH; Zhu J; Fotsch C; Bo Y; Chen N; Chakrabarti P; Doherty EM; Gavva NR; Nishimura N; Nixey T; Ognyanov VI; Rzasa RM; Stec M; Surapaneni S; Tamir R; Viswanadhan VN; Treanor JJ
    J Med Chem; 2007 Jul; 50(15):3497-514. PubMed ID: 17585749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel highly potent and selective sigma 1 receptor antagonists related to spipethiane.
    Piergentili A; Amantini C; Del Bello F; Giannella M; Mattioli L; Palmery M; Perfumi M; Pigini M; Santoni G; Tucci P; Zotti M; Quaglia W
    J Med Chem; 2010 Feb; 53(3):1261-9. PubMed ID: 20067271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 1,4-dioxane, a suitable scaffold for the development of novel M₃ muscarinic receptor antagonists.
    Del Bello F; Barocelli E; Bertoni S; Bonifazi A; Camalli M; Campi G; Giannella M; Matucci R; Nesi M; Pigini M; Quaglia W; Piergentili A
    J Med Chem; 2012 Feb; 55(4):1783-7. PubMed ID: 22243489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and biological evaluation of the 1-arylpyrazole class of σ(1) receptor antagonists: identification of 4-{2-[5-methyl-1-(naphthalen-2-yl)-1H-pyrazol-3-yloxy]ethyl}morpholine (S1RA, E-52862).
    Díaz JL; Cuberes R; Berrocal J; Contijoch M; Christmann U; Fernández A; Port A; Holenz J; Buschmann H; Laggner C; Serafini MT; Burgueño J; Zamanillo D; Merlos M; Vela JM; Almansa C
    J Med Chem; 2012 Oct; 55(19):8211-24. PubMed ID: 22784008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis and pharmacological evaluation of spirocyclic σ(1) receptor ligands with exocyclic amino moiety (increased distance 1).
    Rack E; Fröhlich R; Schepmann D; Wünsch B
    Bioorg Med Chem; 2011 May; 19(10):3141-51. PubMed ID: 21531141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemoenzymatic synthesis of 2,6-disubstituted tetrahydropyrans with high σ
    Kopp N; Civenni G; Marson D; Laurini E; Pricl S; Catapano CV; Humpf HU; Almansa C; Nieto FR; Schepmann D; Wünsch B
    Eur J Med Chem; 2021 Jul; 219():113443. PubMed ID: 33901806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microwave assisted synthesis of spirocyclic pyrrolidines -σ1 receptor ligands with modified benzene-N-distance.
    Jasper A; Schepmann D; Lehmkuhl K; Vela JM; Buschmann H; Holenz J; Wünsch B
    Eur J Med Chem; 2012 Jul; 53():327-36. PubMed ID: 22578786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological characterization and appetite suppressive properties of BMS-193885, a novel and selective neuropeptide Y(1) receptor antagonist.
    Antal-Zimanyi I; Bruce MA; Leboulluec KL; Iben LG; Mattson GK; McGovern RT; Hogan JB; Leahy CL; Flowers SC; Stanley JA; Ortiz AA; Poindexter GS
    Eur J Pharmacol; 2008 Aug; 590(1-3):224-32. PubMed ID: 18573246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and biological evaluation of novel 6,7-dihydro-5H-cyclopenta[d]pyrimidine and 5,6,7,8-tetrahydroquinazoline derivatives as sigma-1 (σ1) receptor antagonists for the treatment of pain.
    Lan Y; Songyang Y; Zhang L; Peng Y; Song J
    Bioorg Med Chem Lett; 2016 Apr; 26(8):2051-6. PubMed ID: 26947609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spirocyclic delta opioid receptor agonists for the treatment of pain: discovery of N,N-diethyl-3-hydroxy-4-(spiro[chromene-2,4'-piperidine]-4-yl) benzamide (ADL5747).
    Le Bourdonnec B; Windh RT; Leister LK; Zhou QJ; Ajello CW; Gu M; Chu GH; Tuthill PA; Barker WM; Koblish M; Wiant DD; Graczyk TM; Belanger S; Cassel JA; Feschenko MS; Brogdon BL; Smith SA; Derelanko MJ; Kutz S; Little PJ; DeHaven RN; DeHaven-Hudkins DL; Dolle RE
    J Med Chem; 2009 Sep; 52(18):5685-702. PubMed ID: 19694468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antihyperalgesic effects of (R,E)-N-(2-hydroxy-2,3-dihydro-1H-inden-4-yl)-3-(2-(piperidin-1-yl)-4-(trifluoromethyl)phenyl)-acrylamide (AMG8562), a novel transient receptor potential vanilloid type 1 modulator that does not cause hyperthermia in rats.
    Lehto SG; Tamir R; Deng H; Klionsky L; Kuang R; Le A; Lee D; Louis JC; Magal E; Manning BH; Rubino J; Surapaneni S; Tamayo N; Wang T; Wang J; Wang J; Wang W; Youngblood B; Zhang M; Zhu D; Norman MH; Gavva NR
    J Pharmacol Exp Ther; 2008 Jul; 326(1):218-29. PubMed ID: 18420600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design of potent, orally available antagonists of the transient receptor potential vanilloid 1. Structure-activity relationships of 2-piperazin-1-yl-1H-benzimidazoles.
    Ognyanov VI; Balan C; Bannon AW; Bo Y; Dominguez C; Fotsch C; Gore VK; Klionsky L; Ma VV; Qian YX; Tamir R; Wang X; Xi N; Xu S; Zhu D; Gavva NR; Treanor JJ; Norman MH
    J Med Chem; 2006 Jun; 49(12):3719-42. PubMed ID: 16759115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.